The accelerator is a mentorship program for companies working with generative artificial intelligence. Ordaos was one of 21 companies selected for the program, according to a May 31 Ordaos news release.
The company will use the accelerator program to find biopharma partners.
“At Ordaos, we believe that the evolution of AI and machine learning will ultimately lead to nothing less than a true paradigm shift in how early drug design, no longer discovery, is done,” Ordaos CEO David Longo said. Our mission at Ordaos is to define the design standard and we are excited to learn from other visionaries in the program to help advance our efforts.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
